Carlo Lombardi Selected Research

Therapeutics

7/2021	Asthma and COVID-19: a dangerous liaison?
2/2021	Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life.
1/2021	Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension.
1/2020	Long-term responsiveness to mepolizumab after failure of omalizumab and bronchial thermoplasty: Two triple-switch case reports.
1/2020	Left Ventricular Size Predicts Clinical Benefit After Percutaneous Mitral Valve Repair for Secondary Mitral Regurgitation: A Systematic Review and Meta-Regression Analysis.
1/2019	Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry.
1/2019	The Characteristics of Severe Chronic Upper-Airway Disease (SCUAD) in Patients with Allergic Rhinitis: A Real-Life Multicenter Cross-Sectional Italian Study.
1/2018	Erratum to "A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure" [Int. J. Cardiol. 250 (2018) 215-222].
1/2018	A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure.
5/2017	Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlo Lombardi Research Topics

Disease

34	Heart Failure 01/2022 - 08/2007
30	Asthma (Bronchial Asthma) 01/2022 - 07/2003
9	Hypersensitivity (Allergy) 01/2022 - 07/2003
7	COVID-19 01/2022 - 12/2020
5	Inflammation (Inflammations) 01/2022 - 08/2011
5	Rhinitis 01/2017 - 07/2003
4	Allergic Rhinitis 10/2021 - 01/2007
4	Pulmonary Arterial Hypertension 01/2021 - 02/2009
3	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2020 - 05/2017
3	Myocardial Infarction 01/2019 - 10/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2018 - 01/2016
2	Anaphylaxis (Anaphylactic Shock) 01/2022 - 12/2015
2	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022 - 01/2022
2	Overweight 01/2021 - 01/2020
2	Hypotension (Low Blood Pressure) 01/2020 - 10/2010
2	Renal Insufficiency (Renal Failure) 01/2018 - 01/2007
2	Seasonal Allergic Rhinitis (Hay Fever) 01/2017 - 01/2017
2	Cardio-Renal Syndrome 12/2016 - 07/2016
1	Stroke (Strokes) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	Hemorrhage 01/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Obesity 01/2021
1	Injection Site Reaction 01/2020
1	Exercise-Induced Asthma (Asthma, Exercise Induced) 01/2020
1	Endomyocardial Fibrosis 01/2019
1	Iron Deficiencies 12/2018
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 11/2018
1	Shock 11/2018
1	Edema (Dropsy) 11/2018
1	Malnutrition (Nutritional Deficiencies) 07/2016
1	Hypertension (High Blood Pressure) 06/2016

Drug/Important Bio-Agent (IBA)

7	Biological ProductsIBA 01/2022 - 01/2020
7	AllergensIBA 01/2022 - 02/2009
7	mepolizumabIBA 01/2022 - 01/2018
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
5	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021 - 08/2011
5	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2016 - 11/2011
4	TroponinIBA 11/2021 - 01/2011
3	benralizumabIBA 01/2022 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2011
3	Immunoglobulin E (IgE)IBA 01/2022 - 08/2014
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 08/2005
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 08/2011
3	CarnosineIBA 01/2016 - 01/2015
3	Amino Acids FDA Link 01/2015 - 10/2012
2	reslizumabIBA 01/2022 - 07/2021
2	Monoclonal AntibodiesIBA 10/2021 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2020 - 10/2019
2	Carbon DioxideIBA 01/2020 - 01/2019
2	Mineralocorticoid Receptor AntagonistsIBA 01/2018 - 09/2015
2	TabletsIBA 01/2017 - 01/2017
2	pro-brain natriuretic peptide (1-76)IBA 11/2016 - 01/2014
2	MicronutrientsIBA 07/2016 - 01/2015
2	Spironolactone (Aldactone)FDA LinkGeneric 09/2015 - 04/2014
2	Troponin T (Troponin T1)IBA 08/2012 - 11/2011
2	CreatinineIBA 04/2012 - 01/2012
2	Furosemide (Lasix)FDA LinkGeneric 06/2011 - 02/2008
2	Endothelin Receptors (Endothelin Receptor)IBA 01/2011 - 02/2009
1	lebrikizumabIBA 01/2022
1	dupilumabIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Interleukin-5 (Interleukin 5)IBA 01/2022
1	Interleukin-4 (Interleukin 4)IBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2022
1	GoldIBA 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 01/2022
1	Angiotensin IIIBA 01/2021
1	Omalizumab (Xolair)FDA Link 01/2020
1	Uric Acid (Urate)IBA 01/2020
1	IstaroximeIBA 01/2020
1	SteroidsIBA 10/2019
1	ferric carboxymaltoseIBA 12/2018
1	Hemoglobins (Hemoglobin)IBA 12/2018
1	Arthropod VenomsIBA 12/2018
1	IronIBA 12/2018
1	Ferritins (Ferritin)IBA 12/2018
1	GadoliniumIBA 11/2018
1	Dobutamine FDA LinkGeneric 11/2018
1	AlbuminsIBA 01/2018
1	LipocalinsIBA 01/2018
1	Urea (Carbamide)FDA LinkGeneric 03/2016
1	NitrogenIBA 03/2016

Therapy/Procedure

21	Therapeutics 07/2021 - 07/2003
5	Patient Readmission 01/2021 - 11/2016
4	Immunotherapy 01/2019 - 01/2007
2	Heart Transplantation (Grafting, Heart) 11/2018 - 01/2015
1	Precision Medicine 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Critical Care (Surgical Intensive Care) 12/2020
1	Self Administration (Administration, Self) 01/2020
1	Transplantation 01/2019
1	Length of Stay 01/2018
1	Mediterranean Diet 06/2016
1	Dietary Approaches To Stop Hypertension 06/2016
1	Injections 12/2015